492 A phase II, placebo-controlled study of merimepodib (XV-497), in combination with pegylated interferon-alfa, and ribavirin in patients with chronic hepatitis C non-responsive to previous therapy with interferon-alfa and ribavirin

2004 ◽  
Vol 40 ◽  
pp. 145 ◽  
Author(s):  
P. Marcellin ◽  
Y. Horsmans ◽  
F. Nevens ◽  
J.D. Grange ◽  
J.P. Bronowicki ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Phase Ii ◽  
Pegylated Interferon ◽  
Interferon Alfa ◽  
Controlled Study ◽  
Previous Therapy ◽  
Pegylated Interferon Alfa

scholarly journals Pegylated interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4 in adolescents

2010 ◽  
Vol 9 (2) ◽  
pp. 156-160 ◽  
Author(s):  
Jaber Al Ali ◽  
Salem Owayed ◽  
Wafa’a Al-Qabandi ◽  
Khaled Husain ◽  
Fuad Hasan
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Pegylated Interferon ◽  
Interferon Alfa ◽  
Genotype 4 ◽  
Pegylated Interferon Alfa

Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4

2009 ◽  
Vol 81 (9) ◽  
pp. 1576-1583 ◽  
Author(s):  
Hesham El Makhzangy ◽  
Gamal Esmat ◽  
Mohamed Said ◽  
Maissa ElRaziky ◽  
Soheir Shouman ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Pegylated Interferon ◽  
Interferon Alfa ◽  
Genotype 4 ◽  
Pegylated Interferon Alfa
Sign in / Sign up

Export Citation Format

Share Document